2001-01-11T00:00:00
The Multiple Sclerosis Society has condemned as 'breathtaking bungling' the announcement by the National Institute for Clinical Excellence that no decision on the drugs beta interferon and glatiramer acetate will be made before July 2001. NICE said new evidence had come to light which needed to be taken into account.
With a HSJ subscription you’ll unlock:
HSJ is part of Wilmington Healthcare Limited. Company number 2530185. c/o Wilmington plc, 5th Floor, 10 Whitechapel High Street, London E1 8QS. Registered in England and Wales. Company registration 30158470
Site powered by Webvision Cloud